FDA Proposes Inclusion of Bemotrizinol in U.S. Sunscreen Formulations
The Food and Drug Administration (FDA) has announced a proposal to allow the use of bemotrizinol, a UV light filter, in U.S. sunscreen products. This ingredient has been widely used in Europe, Australia, and some Asian countries. Bemotrizinol is known for its broad-spectrum protection against both UVA and UVB rays, which are responsible for skin aging and burning, respectively. Unlike many chemical filters currently available in the U.S., bemotrizinol does not degrade upon exposure to sunlight, offering more stable protection. The proposal comes as part of an effort to enhance the effectiveness of sunscreens available in the U.S., where current chemical filters typically require a combination to achieve broad-spectrum coverage.